Accumulating evidence suggests that the fourth dose of the messenger RNA vaccines for covid 19, which in Spain are those of Moderna and Pfizer, will be especially essential to provide greater protection to people with more vulnerable immune systems and older people. Published works in the month of December They show, however, that a fourth dose is not capable of increasing or prolonging the immune response that had already been generated with the third dose.
